February 7, 2017

eConsent comes of age

FDA guidelines published in December on the use of electronic informed consent (eConsent) in clinical trials have given fresh encouragement to sponsors to consider it over traditional, paper-based methods. In the first of two podcasts on the topic, Tudor Reilly Health founder Peter Coë talks to Kahmen Lai about the benefits eConsent can bring and why the time is right for the industry to adopt it.


Facebook ad grab

Read More

Tudor Reilly Health joins Britain's most ambitious enterprises

Read More